EGM
TPST icon

Engineers Gate Manager’s Tempest Therapeutics TPST Stock Holding History

Engineers Gate Manager’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,807
Closed -$19.6K – 2587
2024
Q4 		$19.6K Buy
+1,807
New +$23.3K ﹤0.01% 2158

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Engineers Gate Manager's TPST Position: Q1 2025 in Review

Engineers Gate Manager sold out of Tempest Therapeutics (TPST) in Q1 2025, closing a stake of 1,807 shares — an estimated $19.6K sold.

Engineers Gate Manager first reported a position in TPST in Q4 2024 and held it in 1 quarter. The position peaked at $19.6K in Q4 2024. 23 funds tracked by Wall St. Rank hold TPST as of Q1 2025.

  • Engineers Gate Manager reported no remaining Tempest Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 1,807 Tempest Therapeutics shares in Q1 2025, an estimated $19.6K.
  • Engineers Gate Manager first reported a position in Tempest Therapeutics in Q4 2024 and held it in 1 quarter.
  • Engineers Gate Manager's Tempest Therapeutics position peaked at $19.6K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2025.

Based on Engineers Gate Manager's 13F filing for Q1 2025, filed 15 May 2025.